普利制药 (300630.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(普利制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 518,193,841.85460,874,059.64373,166,292.20435,653,365.55575,087,948.20427,677,766.99367,925,505.63
 营业收入(元) 518,193,841.85460,874,059.64373,166,292.20435,653,365.55575,087,948.20427,677,766.99367,925,505.63
二、营业总成本(元) 383,575,609.40341,839,758.76243,515,781.30481,100,192.91382,311,161.97306,648,248.45212,061,775.12
 营业成本(元) 184,558,134.25148,439,563.82104,661,902.17296,733,920.85125,269,360.71119,542,563.1475,414,788.75
 研发费用(元) 98,122,072.6970,200,782.4361,517,923.074,800,110.75125,781,224.6875,798,068.6656,659,055.19
 营业税金及附加(元) 1,163,681.862,207,034.822,374,980.848,222,891.921,188,802.711,130,402.441,666,012.59
 销售费用(元) 52,354,284.8076,181,716.9651,140,496.07179,550,278.1469,411,984.1553,984,426.0147,706,957.68
 管理费用(元) 34,979,583.8138,429,595.2715,061,173.0123,579,410.3235,056,571.0635,966,081.9912,716,584.11
 财务费用(元) 12,397,851.996,381,065.468,759,306.14-31,786,419.0725,603,218.6620,226,706.2117,898,376.80
  其中:利息费用(元) 12,260,028.85---27,738,682.2525,319,801.19--
  其中:利息收入(元) 571,198.91--1,473,299.17-290,396.12--
 信用减值损失(元) -24,113,860.05-8,359,990.25-1,694,678.6512,571,426.06-22,879,029.512,302,258.26-1,250,138.89
三、其他经营收益
 加:投资收益(元) 1,405,772.38671,139.282,463,766.47-3,185,471.29-1,642,487.24141,101.23
 其他收益(元) 21,061,443.4927,784,543.539,070,325.654,883,202.661,724,784.506,406,906.7813,015,588.30
四、营业利润(元) 132,971,588.27138,528,376.69139,489,924.37-31,272,113.11171,622,541.22131,381,170.82167,770,281.15
 加:营业外收入(元) 38,706.5782,469.0119,399.7770,012.4073,032.8712,560.3517,965.60
 减:营业外支出(元) 177,914.4614,865.8682.03757,898.03937.22--
五、利润总额(元) 132,832,380.38138,595,979.84139,509,242.11-31,959,998.74171,694,636.87131,393,626.77167,788,246.75
 减:所得税费用(元) -1,522,359.997,083,506.301,076,155.702,888,424.103,841,902.285,560,199.026,010,278.61
六、净利润(元) 134,354,740.37131,512,473.54138,433,086.41-34,848,422.84167,852,734.59125,833,427.75161,777,968.14
(一)按经营持续性分类
  持续经营净利润(元) 134,354,740.37131,512,473.54138,433,086.41-34,848,422.84167,852,734.59125,833,427.75161,777,968.14
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 134,354,740.37131,512,473.54138,433,086.41-34,848,422.84167,852,734.59125,833,427.75161,777,968.14
 扣除非经常性损益后的净利润(元) 116,215,968.02107,491,634.32128,887,445.84-38,239,732.86166,707,740.65120,933,193.53148,627,173.03
七、每股收益
 一、基本每股收益(元) 0.310.300.32-0.080.380.290.37
 二、稀释每股收益(元) 0.280.240.32-0.140.410.260.37
九、综合收益总额(元) 134,354,740.37131,512,473.54138,433,086.41-34,848,422.84167,852,734.59125,833,427.75161,777,968.14
 归属于母公司所有者的综合收益总额(元) 134,354,740.37131,512,473.54138,433,086.41-34,848,422.84167,852,734.59125,833,427.75161,777,968.14
公告日期 2023-10-252023-08-252023-04-252023-04-252022-10-252022-08-302022-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院